new drug approval
Scope
Date
~
-
Bio & Pharma
LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn
South Korean pharmaceutical firm LegoChem Biosciences Inc. said on Dec. 23 it has transferred the antibody-drug conjugates (ADC) technology platform...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Dong-A ST incorporates NeuroBo as subsidiary
Dong-A ST said on Friday that it would acquire American drug company NeuroBo Pharmaceuticals as a subsidiary.NeuroBo, located in Boston, is a Nasdaq...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for FDA approval for Remsima SC
Celltrion Ltd. said on Friday it had applied the previous day for permission from the US Food and Drug Administration (FDA) for Remsima SC, an autoi...
Dec 23, 2022 (Gmt+09:00)
-
Electric vehicles
SK Signet to showcase new ultra-fast charger at CES 2023
SK Signet Inc., the No.1 company in the US ultra-high speed charger market, will showcase a new standard ultra-fast charger V2 at CES 2023, the worl...
Dec 22, 2022 (Gmt+09:00)
-
Electronics
SK Broadband develops eco-friendly rechargable remote control
South Korea's internet service provider SK Broadband has developed a new B tv remote control that can be recharged with significantly reduced chargi...
Dec 22, 2022 (Gmt+09:00)
-
Petrochemicals
Hyundai Heavy develops new chemical-resistant paint for PC carriers
Hyundai Heavy Industries Group said Wednesday that it has developed a paint product for petrochemical product (PC) carriers with significantly impro...
Dec 21, 2022 (Gmt+09:00)
-
Bio & Pharma
S.Korean biopharmaceutical sector to see brisk M&As in H1, 2023
An expert says the first half of next year will see the start of brisk M&As in biopharmaceuticals targeting strategic investors.Pyeon Jae-seong,...
Dec 21, 2022 (Gmt+09:00)
-
Electric vehicles
Hyundai Motor's compact SUV Kona gets bigger
Hyundai Motor Co. on Tuesday unveiled the new design of its compact SUV the new "all-new Kona."The all-new Kona is a second-generation model being i...
Dec 20, 2022 (Gmt+09:00)
-
Executive reshuffles
Hyundai becomes younger with 1 in 3 new executives in their 40s
South Korea’s Hyundai Motor Group, which owns Hyundai Motor Co. and Kia Corp., has carried out a year-end mid-tier executive reshuffle marked ...
Dec 20, 2022 (Gmt+09:00)
-
Carbon neutrality
Samsung Heavy receives approval from US on gas recovery system
Samsung Heavy Industries, a major shipbuilder in South Korea, said on Tuesday that its boil-off gas recovery system (BReS) for LNG-powered vessels h...
Dec 20, 2022 (Gmt+09:00)
-
Artificial intelligence
Syntekabio launches new drug development platform STB Cloud in US
Syntekabio,Inc., a South Korean artificial intelligence (AI) drug development company, said on Monday it has launched its cloud-based AI drug develo...
Dec 19, 2022 (Gmt+09:00)
-
Batteries
Leaders of Samsung, BMW discuss bolstering EV battery partnership
Samsung Electronics Chairman Jay Y. Lee met with the Chairman of the Management Board of BMW Group Oliver Zipse on Saturday to discuss ways to deepe...
Dec 18, 2022 (Gmt+09:00)
-
Corporate strategy
Samsung eyes new mobile AP chip to take on Apple's iPhone
Samsung Electronics Co. and Apple Inc. have had a long rivalry in the global market for smartphones and other mobile devices. In terms of sales...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem in $95.5 million drug out-licensing deal with China’s Innovent
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., and China’s biotech company Innovent Biologics have entered into a strategi...
Dec 15, 2022 (Gmt+09:00)
-
Chemical Industry
Daewoo Shipbuilding, POSCO jointly develop new materials
South Korea's Daewoo Shipbuilding & Marine Engineering Co. (DSME) and steelmaker POSCO have joined forces to develop new materials.DSME on Wedne...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Helixmith acquires US patent on new freeze-dried formulation
South Korea's biotech company Helixmith Co. said Wednesday it has developed and patented a new freeze-dried formulation for Engensis (VM202), a non-...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Daewoong submits new drug applications for Fexuclue in 10 countries
South Korea's leading drug company Daewoong Pharmaceutical is accelerating its global expansion efforts for its 34th domestically developed drug Fex...
Dec 14, 2022 (Gmt+09:00)
-
Electronics
SK C&C to automate production process of SKC's US subsidiary
SK C&C announced on Wednesday that it will start a project to install a full-process automation system based on its smart factory platform I-FAC...
Dec 14, 2022 (Gmt+09:00)
-
Logistics
CJ Logistics expands global e-commerce shipping services
South Korea’s CJ Logistics Corp. is ramping up its cross-border e-commerce (CBE) businesses as its local rival Coupang Inc. is increasing domi...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
LX International wins conditional approval to acquire HanGlas
The Korean Fair Trade Commission said on Monday that it had conditionally approved LX International Corp.'s bid to acquire Hankuk Glass Industries (...
Dec 13, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials
LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...
Dec 13, 2022 (Gmt+09:00)
-
Research & Development
LG Group seeks future growth engines with new R&D units
LG Group, South Korea’s fourth-largest conglomerate, set up new research and development units at key affiliates to seek future growth engines...
Dec 12, 2022 (Gmt+09:00)
-
Healthcare
South Korea passes new law making everyone a little younger
SEOUL—As the rest of the world ages, South Koreans are getting younger.South Korea’s parliament passed laws Thursday abolishing the trad...
Dec 12, 2022 (Gmt+09:00)
-
Bio & Pharma
New drug developer Onconic Therapeutics raises $20 mn in Series B
South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...
Dec 09, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals launches epilepsy drug in France
South Korean SK Biopharmaceuticals Co. said on Friday that its treatment of epilepsy "Cenobamate" has been approved for sale in France.The company l...
Dec 09, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
SK Telecom gets global approval for UAM-interworking tech standard
South Korea's SK Telecom Co. on Thursday said the International Telecommunication Union's Telecommunication Standardization Sector (ITU-T) approved ...
Dec 09, 2022 (Gmt+09:00)
-
Logistics
Doosan Logistics clinches deal to build Daiso's new hub center
South Korean system integrator Doosan Logistics Solution (DLS) has won a deal to build a new distribution center at 75 billion won ( $57 million)....
Dec 08, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
LG Uplus poised to acquire homegrown OTT platform Watcha
South Korea’s third-largest mobile carrier LG Uplus Corp. is slated to acquire homegrown over-the-top (OTT) platform Watcha Inc., investment b...
Dec 06, 2022 (Gmt+09:00)
-
Automobiles
Hyundai's sales of E-GMP-based EVs exceed 100,000 units in Korea
South Korea’s Hyundai Motor Group sold more than 100,000 units of electric vehicles (EVs) that adopted Hyundai Motor’s E-GMP, or Electri...
Dec 06, 2022 (Gmt+09:00)
Latest News
- 1 Copycat Korean goods flood global e-commerce platforms
- 2 Xiaomi to open first offline store in S.Korea with premium products
- 3 Loss-making Lotte Chemical to sell water treatment unit to Synopex
- 4 Google to invest $100 mn in Gentle Monster in smart glasses push
- 5 Growth equity portfolio largely shielded from policy headwinds: Summit